Published in Hum Mol Genet on August 01, 1999
Phosphorylation of the PTEN tail regulates protein stability and function. Mol Cell Biol (2000) 5.22
Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics (2009) 4.31
A developmental and genetic classification for malformations of cortical development: update 2012. Brain (2012) 3.14
Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice. J Neurosci (2009) 2.90
mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo. Proc Natl Acad Sci U S A (2003) 2.68
A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands. Am J Hum Genet (2010) 2.59
A developmental and genetic classification for midbrain-hindbrain malformations. Brain (2009) 2.47
Protean PTEN: form and function. Am J Hum Genet (2002) 2.43
Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. Am J Pathol (2000) 2.27
Epigenetic PTEN silencing in malignant melanomas without PTEN mutation. Am J Pathol (2000) 2.23
PTEN mutational spectra, expression levels, and subcellular localization in microsatellite stable and unstable colorectal cancers. Am J Pathol (2002) 2.16
Germline PTEN promoter mutations and deletions in Cowden/Bannayan-Riley-Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. Am J Hum Genet (2003) 1.94
Hereditary colorectal cancer syndromes: molecular genetics, genetic counseling, diagnosis and management. Fam Cancer (2007) 1.82
Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Am J Pathol (2001) 1.82
Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan-Riley-Ruvalcaba syndromes. Am J Hum Genet (2001) 1.81
Reversing neurodevelopmental disorders in adults. Neuron (2008) 1.80
Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. Am J Med Genet B Neuropsychiatr Genet (2007) 1.65
Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia. PLoS One (2008) 1.64
The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management. J Med Genet (2007) 1.64
Differential expression of PTEN-targeting microRNAs miR-19a and miR-21 in Cowden syndrome. Am J Hum Genet (2008) 1.59
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet (2002) 1.57
Hamartomatous polyposis syndromes. Surg Clin North Am (2008) 1.55
Cancer and Lhermitte-Duclos disease are common in Cowden syndrome patients. Hered Cancer Clin Pract (2010) 1.49
Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults. Am J Hum Genet (2003) 1.41
Cowden syndrome-affected patients with PTEN promoter mutations demonstrate abnormal protein translation. Am J Hum Genet (2007) 1.39
Role of APC and DNA mismatch repair genes in the development of colorectal cancers. Mol Cancer (2003) 1.34
Recurrent 10q22-q23 deletions: a genomic disorder on 10q associated with cognitive and behavioral abnormalities. Am J Hum Genet (2007) 1.34
Ras and Rap signaling in synaptic plasticity and mental disorders. Neuroscientist (2010) 1.29
Pathology of hereditary breast cancer. Cell Oncol (Dordr) (2011) 1.28
Peutz-Jeghers families unlinked to STK11/LKB1 gene mutations are highly predisposed to primitive biliary adenocarcinoma. J Med Genet (2001) 1.27
Incidence and clinical characteristics of thyroid cancer in prospective series of individuals with Cowden and Cowden-like syndrome characterized by germline PTEN, SDH, or KLLN alterations. J Clin Endocrinol Metab (2011) 1.25
Analysis of prevalence and degree of macrocephaly in patients with germline PTEN mutations and of brain weight in Pten knock-in murine model. Eur J Hum Genet (2011) 1.25
Contiguous gene deletion within chromosome arm 10q is associated with juvenile polyposis of infancy, reflecting cooperation between the BMPR1A and PTEN tumor-suppressor genes. Am J Hum Genet (2006) 1.24
Cdx2 regulates endo-lysosomal function and epithelial cell polarity. Genes Dev (2010) 1.21
Hamartomatous polyposis syndromes. Best Pract Res Clin Gastroenterol (2009) 1.18
Male breast cancer in Cowden syndrome patients with germline PTEN mutations. J Med Genet (2001) 1.17
The differential diagnosis of familial lentiginosis syndromes. Fam Cancer (2011) 1.12
Therapeutic role of mammalian target of rapamycin (mTOR) inhibition in preventing epileptogenesis. Neurosci Lett (2011) 1.12
Mammalian target of rapamycin (mTOR) inhibition: potential for antiseizure, antiepileptogenic, and epileptostatic therapy. Curr Neurol Neurosci Rep (2012) 1.09
Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: results of a clinical study of PTEN mutation carriers. J Med Genet (2007) 1.08
Genetics of skin appendage neoplasms and related syndromes. J Med Genet (2005) 1.08
Allele-specific tumor spectrum in pten knockin mice. Proc Natl Acad Sci U S A (2010) 1.08
PTEN hamartoma of soft tissue: a distinctive lesion in PTEN syndromes. Am J Surg Pathol (2012) 1.05
Mapping of hereditary mixed polyposis syndrome (HMPS) to chromosome 10q23 by genomewide high-density single nucleotide polymorphism (SNP) scan and identification of BMPR1A loss of function. J Med Genet (2006) 1.03
Phosphoinositide phosphatases in a network of signalling reactions. Pflugers Arch (2007) 1.03
Finding a better drug for epilepsy: the mTOR pathway as an antiepileptogenic target. Epilepsia (2012) 1.02
Detection of functional PTEN lipid phosphatase protein and enzyme activity in squamous cell carcinomas of the head and neck, despite loss of heterozygosity at this locus. Br J Cancer (2001) 1.01
Aberrant AKT activation drives well-differentiated liposarcoma. Proc Natl Acad Sci U S A (2011) 1.00
Distinct expression profiles for PTEN transcript and its splice variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome. Am J Hum Genet (2006) 1.00
Estimate of de novo mutation frequency in probands with PTEN hamartoma tumor syndrome. Genet Med (2012) 0.99
Hereditary hamartomatous polyposis syndromes: understanding the disease risks as children reach adulthood. Gastroenterol Hepatol (N Y) (2010) 0.99
The PTEN/PI3K/AKT Pathway in vivo, Cancer Mouse Models. Front Oncol (2014) 0.96
Mechanisms regulating neuronal excitability and seizure development following mTOR pathway hyperactivation. Front Mol Neurosci (2014) 0.95
Genetics of the hamartomatous polyposis syndromes: a molecular review. Int J Colorectal Dis (2009) 0.95
Germline PTEN mutations are rare and highly penetrant. Hered Cancer Clin Pract (2006) 0.94
Planarian PTEN homologs regulate stem cells and regeneration through TOR signaling. Dis Model Mech (2008) 0.93
Adult reversal of cognitive phenotypes in neurodevelopmental disorders. J Neurodev Disord (2009) 0.93
Bannayan-Riley-Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases. Fam Cancer (2003) 0.92
Inhibition of endothelial nitric oxide synthase by the lipid phosphatase PTEN. Vascul Pharmacol (2009) 0.92
Frequency of germline PTEN mutations in differentiated thyroid cancer. Thyroid (2011) 0.92
Papillary renal cell carcinoma is associated with PTEN hamartoma tumor syndrome. Urology (2012) 0.91
Rapid mutation scanning of genes associated with familial cancer syndromes using denaturing high-performance liquid chromatography. Neoplasia (2001) 0.89
Molecular Genetics of Colorectal Cancer: An Overview. Curr Colorectal Cancer Rep (2006) 0.87
Exploring the gain of function contribution of AKT to mammary tumorigenesis in mouse models. PLoS One (2010) 0.87
Cowden syndrome-associated germline SDHD variants alter PTEN nuclear translocation through SRC-induced PTEN oxidation. Hum Mol Genet (2014) 0.86
Juvenile polyposis and other intestinal polyposis syndromes with microdeletions of chromosome 10q22-23. Clin Genet (2011) 0.86
Genetic counseling and testing for common hereditary breast cancer syndromes: a paper from the 2007 William Beaumont hospital symposium on molecular pathology. J Mol Diagn (2008) 0.86
Colonic manifestations of PTEN hamartoma tumor syndrome: case series and systematic review. World J Gastroenterol (2014) 0.84
Involvement of tumor suppressors PTEN and p53 in the formation of multiple subtypes of liposarcoma. Cell Death Differ (2015) 0.84
Storiform collagenoma as a clue for Cowden disease or PTEN hamartoma tumour syndrome. J Clin Pathol (2007) 0.84
PTEN germline mutations in patients initially tested for other hereditary cancer syndromes: would use of risk assessment tools reduce genetic testing? Oncologist (2013) 0.84
mTOR, a Potential Target to Treat Autism Spectrum Disorder. CNS Neurol Disord Drug Targets (2016) 0.84
Cowden Syndrome with a Novel Germline PTEN Mutation and an Unusual Clinical Course. Ann Dermatol (2015) 0.83
Mutation-positive and mutation-negative patients with Cowden and Bannayan-Riley-Ruvalcaba syndromes associated with distinct 10q haplotypes. Am J Hum Genet (2006) 0.83
PPARgamma, PTEN, and the Fight against Cancer. PPAR Res (2008) 0.82
Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma. Br J Cancer (2001) 0.82
PTEN gene: a model for genetic diseases in dermatology. ScientificWorldJournal (2012) 0.81
Cognitive characteristics of PTEN hamartoma tumor syndromes. Genet Med (2013) 0.81
Utility of PTEN protein dosage in predicting for underlying germline PTEN mutations among patients presenting with thyroid cancer and Cowden-like phenotypes. J Clin Endocrinol Metab (2012) 0.81
Characteristic brain magnetic resonance imaging pattern in patients with macrocephaly and PTEN mutations. Am J Med Genet A (2013) 0.80
Bannayan-Riley-Ruvalcaba syndrome with deforming lipomatous hamartomas in infant--case report. An Bras Dermatol (2014) 0.80
Characteristics of Small Bowel Polyps Detected in Cowden Syndrome by Capsule Endoscopy. Case Rep Gastrointest Med (2015) 0.80
A 39-bp deletion polymorphism in PTEN in African American individuals: implications for molecular diagnostic testing. J Mol Diagn (2002) 0.79
Genomic Biomarkers for Breast Cancer Risk. Adv Exp Med Biol (2016) 0.77
New insights into acute lung injury. Vascul Pharmacol (2010) 0.76
Muscle hemangiomatosis presenting as a severe feature in a patient with the pten mutation: expanding the phenotype of vascular malformations in bannayan-riley-ruvalcaba syndrome. Balkan J Med Genet (2012) 0.75
Aggressive juvenile polyposis in children with chromosome 10q23 deletion. World J Gastroenterol (2013) 0.75
Mosaic Disorders of the PI3K/PTEN/AKT/TSC/mTORC1 Signaling Pathway. Dermatol Clin (2017) 0.75
Neuroendocrine Tumor of the Pancreas as a Manifestation of Cowden Syndrome: A Case Report. J Clin Endocrinol Metab (2015) 0.75
Cowden syndrome. Managing multiple skeletal metastases of different origin: a case report. Cases J (2008) 0.75
Hereditary Syndromes Manifesting as Endometrial Carcinoma: How Can Pathological Features Aid Risk Assessment? Biomed Res Int (2015) 0.75
Thyroid involvement in two patients with Bannayan-Riley-Ruvalcaba syndrome. J Clin Res Pediatr Endocrinol (2013) 0.75
Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst (2000) 16.92
Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet (1997) 10.71
Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature (1987) 10.21
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Catalytic specificity of protein-tyrosine kinases is critical for selective signalling. Nature (1995) 6.16
Identification of bacteria by computer: general aspects and perspectives. J Gen Microbiol (1973) 6.15
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature (1993) 5.81
Is secondary haemorrhage after tonsillectomy in adults an infective condition? Objective measures of infection in a prospective cohort. Clin Otolaryngol (2007) 5.45
On the chemical specificity of precipitins. J Physiol (1905) 5.40
Coloboma, congenital heart disease, and choanal atresia with multiple anomalies: CHARGE association. J Pediatr (1981) 5.35
P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase. Proc Natl Acad Sci U S A (1997) 5.32
Sorafenib in advanced melanoma: a Phase II randomised discontinuation trial analysis. Br J Cancer (2006) 4.93
Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology (1997) 4.86
Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum Mol Genet (1998) 4.72
Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet (2001) 4.71
Nevoid basal-cell carcinoma syndrome. Medicine (Baltimore) (1987) 4.60
A 1.5 million-base pair inversion polymorphism in families with Williams-Beuren syndrome. Nat Genet (2001) 4.58
Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet (1997) 4.39
Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet (2005) 4.14
Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations. Hum Mol Genet (2005) 4.12
Consensus statement on management of intersex disorders. Arch Dis Child (2006) 4.07
AUX1 regulates root gravitropism in Arabidopsis by facilitating auxin uptake within root apical tissues. EMBO J (1999) 4.00
Prostate cancer susceptibility locus on chromosome 1q: a confirmatory study. J Natl Cancer Inst (1997) 3.92
Further delineation of the 15q13 microdeletion and duplication syndromes: a clinical spectrum varying from non-pathogenic to a severe outcome. J Med Genet (2009) 3.87
Complete transformation by adenovirus 2 requires both E1A proteins. Cell (1984) 3.80
The crystal structure of diphtheria toxin. Nature (1992) 3.80
Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell (1987) 3.60
Excessive CpG island hypermethylation in cancer cell lines versus primary human malignancies. Hum Mol Genet (2001) 3.58
Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet (1997) 3.56
Localization of the gene for Cowden disease to chromosome 10q22-23. Nat Genet (1996) 3.53
Training in international animal health. Vet Rec (2001) 3.53
Multiple lentigenes syndrome. Am J Dis Child (1969) 3.39
Comparative anatomy of the aldo-keto reductase superfamily. Biochem J (1997) 3.39
CHARGE association: an update and review for the primary pediatrician. Clin Pediatr (Phila) (1998) 3.33
Plasma homocysteine levels and folate status in children with sickle cell anemia. J Pediatr Hematol Oncol (1999) 3.27
Angelman and Prader-Willi syndromes share a common chromosome 15 deletion but differ in parental origin of the deletion. Am J Med Genet (1989) 3.22
Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut (2010) 3.22
Proteus syndrome: diagnostic criteria, differential diagnosis, and patient evaluation. Am J Med Genet (1999) 3.02
Recent developments in molecular epidemiology: A study of the effects of environmental polycyclic aromatic hydrocarbons on birth outcomes in Poland. Am J Epidemiol (1998) 2.96
Quantitative calibration and use of DNA probes for investigating chromosome abnormalities in the Prader-Willi syndrome. Am J Med Genet (1989) 2.83
Tobacco sponsorship of Formula One and CART auto racing: tobacco brand exposure and enhanced symbolic imagery through co-sponsors' third party advertising. Tob Control (2002) 2.82
Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor. Cell (1998) 2.80
Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast. Am J Pathol (1999) 2.79
Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes. Lancet (2001) 2.77
TERC polymorphisms are associated both with susceptibility to colorectal cancer and with longer telomeres. Gut (2011) 2.75
Loss-of-function mutations in PPAR gamma associated with human colon cancer. Mol Cell (1999) 2.71
The effectiveness of Irlen filters for improving reading performance: a pilot study. J Learn Disabil (1990) 2.68
Pneumococcal bacteraemia in two immunocompetent adults with otitis media and bronchitis. Lancet (1990) 2.59
Microtubule protein. Identification in and transport to nerve endings. J Cell Biol (1971) 2.58
cis-acting sequences required for inducible interleukin-2 enhancer function bind a novel Ets-related protein, Elf-1. Mol Cell Biol (1992) 2.55
The Menkes/Wilson disease gene homologue in yeast provides copper to a ceruloplasmin-like oxidase required for iron uptake. Proc Natl Acad Sci U S A (1995) 2.50
AXR4 is required for localization of the auxin influx facilitator AUX1. Science (2006) 2.49
Calcifying odontogenic cyst. Range, variations and neoplastic potential. Acta Odontol Scand (1981) 2.45
Multidisciplinary cancer conferences: a systematic review and development of practice standards. Eur J Cancer (2007) 2.41
Solitary maxillary central incisor and short stature. J Pediatr (1977) 2.41
Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci U S A (2001) 2.38
Fallacies in medical education. Lancet (1967) 2.33
The syndrome of pits of the lower lip and cleft lip and/or palate. Genetic considerations. Am J Hum Genet (1967) 2.32
Numerical classification of the tribe Klebsielleae. J Gen Microbiol (1971) 2.31
The effect of childbirth on pelvic organ mobility. Obstet Gynecol (2003) 2.29
Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet (2004) 2.29
GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. Nat Genet (1997) 2.28
Mutation and expression analyses reveal differential subcellular compartmentalization of PTEN in endocrine pancreatic tumors compared to normal islet cells. Am J Pathol (2000) 2.27
The APC variants I1307K and E1317Q are associated with colorectal tumors, but not always with a family history. Proc Natl Acad Sci U S A (1998) 2.27
In frame fibrillin-1 gene deletion in autosomal dominant Weill-Marchesani syndrome. J Med Genet (2003) 2.26
The rate of liberation of arginine in tryptic digestion. Biochem J (1930) 2.24
Epigenetic PTEN silencing in malignant melanomas without PTEN mutation. Am J Pathol (2000) 2.23
Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer. Proc Natl Acad Sci U S A (2000) 2.23
Polyclonal origin of colonic adenomas in an XO/XY patient with FAP. Science (1996) 2.22
Cryptic deletions are a common finding in "balanced" reciprocal and complex chromosome rearrangements: a study of 59 patients. J Med Genet (2007) 2.21
Detection of hypoglycemia with the GlucoWatch biographer. Diabetes Care (2001) 2.20
Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics. Am J Med Genet (1997) 2.19
CRAF inhibition induces apoptosis in melanoma cells with non-V600E BRAF mutations. Oncogene (2008) 2.19
Oligomer formation by 3D domain swapping: a model for protein assembly and misassembly. Adv Protein Chem (1997) 2.17
Methylation of the CDH1 promoter as the second genetic hit in hereditary diffuse gastric cancer. Nat Genet (2000) 2.15
Statistical methods for polyploid radiation hybrid mapping. Genome Res (1995) 2.15
Clinical and molecular studies in full trisomy 22: further delineation of the phenotype and review of the literature. Am J Med Genet (1995) 2.15
Recessive Robinow syndrome, allelic to dominant brachydactyly type B, is caused by mutation of ROR2. Nat Genet (2000) 2.14
Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer: implications for clinical predisposition testing. JAMA (1999) 2.14
Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet (1994) 2.14
PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies. Hum Mol Genet (1999) 2.08
Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors. Cancer Res (1997) 2.06
Antenatal screening in Oxford for fetal neural tube defects. Br J Obstet Gynaecol (1979) 2.06
Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet (2000) 2.05
British Paediatric and Adolescent Bone Group's position statement on vitamin D deficiency. BMJ (2012) 2.05
Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am J Pathol (2000) 2.05
Two cases of X/autosome translocation in females with incontinentia pigmenti. Hum Genet (1985) 2.05
Urofacial (ochoa) syndrome. Am J Med Genet (1987) 2.03
Vision characteristics of individuals identified as Irlen Filter candidates. J Am Optom Assoc (1990) 2.03